β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement

A. Morrone, T. Bardelli, M. A. Donati, M. Giorgi, M. Di Rocco, R. Gatti, R. Parini, R. Ricci, G. Taddeucci, A. D'Azzo, E. Zammarchi

Research output: Contribution to journalArticle

Abstract

GM1-gangliosidosis is a lysosomal storage disorder caused by deficiency of acid β-galactosidase (GLB1). We report five new β-galactosidase gene mutations in nine Italian patients and one fetus, segregating in seven unrelated families. Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis. Molecular analysis of the patients' RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions. Interestingly, all patients with cardiac involvement were homozygous for one of these mutations: R59H, Y591C, Y59 IN, or IVS142A>G. In contrast, all other patients were compound heterozygous for one of the following mutations: R201H, R482H, G579D, IVS8+2T> C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ-Gal-related protein, also known as the elastin binding protein (EBP). Consequently, both molecules are affected by the mutations, and they may contribute differently to the occurrence of specific clinical manifestations.

Original languageEnglish
Pages (from-to)354-366
Number of pages13
JournalHuman Mutation
Volume15
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

GM1 Gangliosidosis
Galactosidases
Mutation
Enzymes
Genes
RNA Splicing
Amino Acid Substitution
Cardiomyopathies
elastin-binding proteins
Heart Diseases
Fetus
Complementary DNA
RNA
Acids
DNA

Keywords

  • β-galactosidase
  • Cardiomyopathy
  • EBP
  • Elastin binding protein
  • GLB1
  • GM1-gangliosidosis
  • Lysosomal storage disorder

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. / Morrone, A.; Bardelli, T.; Donati, M. A.; Giorgi, M.; Di Rocco, M.; Gatti, R.; Parini, R.; Ricci, R.; Taddeucci, G.; D'Azzo, A.; Zammarchi, E.

In: Human Mutation, Vol. 15, No. 4, 2000, p. 354-366.

Research output: Contribution to journalArticle

Morrone, A. ; Bardelli, T. ; Donati, M. A. ; Giorgi, M. ; Di Rocco, M. ; Gatti, R. ; Parini, R. ; Ricci, R. ; Taddeucci, G. ; D'Azzo, A. ; Zammarchi, E. / β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. In: Human Mutation. 2000 ; Vol. 15, No. 4. pp. 354-366.
@article{de7fbeddb9ce4d51914878bf030a1b6a,
title = "β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement",
abstract = "GM1-gangliosidosis is a lysosomal storage disorder caused by deficiency of acid β-galactosidase (GLB1). We report five new β-galactosidase gene mutations in nine Italian patients and one fetus, segregating in seven unrelated families. Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis. Molecular analysis of the patients' RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions. Interestingly, all patients with cardiac involvement were homozygous for one of these mutations: R59H, Y591C, Y59 IN, or IVS142A>G. In contrast, all other patients were compound heterozygous for one of the following mutations: R201H, R482H, G579D, IVS8+2T> C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ-Gal-related protein, also known as the elastin binding protein (EBP). Consequently, both molecules are affected by the mutations, and they may contribute differently to the occurrence of specific clinical manifestations.",
keywords = "β-galactosidase, Cardiomyopathy, EBP, Elastin binding protein, GLB1, GM1-gangliosidosis, Lysosomal storage disorder",
author = "A. Morrone and T. Bardelli and Donati, {M. A.} and M. Giorgi and {Di Rocco}, M. and R. Gatti and R. Parini and R. Ricci and G. Taddeucci and A. D'Azzo and E. Zammarchi",
year = "2000",
doi = "10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.0.CO;2-L",
language = "English",
volume = "15",
pages = "354--366",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement

AU - Morrone, A.

AU - Bardelli, T.

AU - Donati, M. A.

AU - Giorgi, M.

AU - Di Rocco, M.

AU - Gatti, R.

AU - Parini, R.

AU - Ricci, R.

AU - Taddeucci, G.

AU - D'Azzo, A.

AU - Zammarchi, E.

PY - 2000

Y1 - 2000

N2 - GM1-gangliosidosis is a lysosomal storage disorder caused by deficiency of acid β-galactosidase (GLB1). We report five new β-galactosidase gene mutations in nine Italian patients and one fetus, segregating in seven unrelated families. Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis. Molecular analysis of the patients' RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions. Interestingly, all patients with cardiac involvement were homozygous for one of these mutations: R59H, Y591C, Y59 IN, or IVS142A>G. In contrast, all other patients were compound heterozygous for one of the following mutations: R201H, R482H, G579D, IVS8+2T> C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ-Gal-related protein, also known as the elastin binding protein (EBP). Consequently, both molecules are affected by the mutations, and they may contribute differently to the occurrence of specific clinical manifestations.

AB - GM1-gangliosidosis is a lysosomal storage disorder caused by deficiency of acid β-galactosidase (GLB1). We report five new β-galactosidase gene mutations in nine Italian patients and one fetus, segregating in seven unrelated families. Six of the eight patients with the infantile, severe form of the disease presented cardiac involvement, a feature rarely associated with GM1-gangliosidosis. Molecular analysis of the patients' RNA and DNA identified two new RNA splicing defects, three new and three previously described amino acid substitutions. Interestingly, all patients with cardiac involvement were homozygous for one of these mutations: R59H, Y591C, Y59 IN, or IVS142A>G. In contrast, all other patients were compound heterozygous for one of the following mutations: R201H, R482H, G579D, IVS8+2T> C. Although we could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ-Gal-related protein, also known as the elastin binding protein (EBP). Consequently, both molecules are affected by the mutations, and they may contribute differently to the occurrence of specific clinical manifestations.

KW - β-galactosidase

KW - Cardiomyopathy

KW - EBP

KW - Elastin binding protein

KW - GLB1

KW - GM1-gangliosidosis

KW - Lysosomal storage disorder

UR - http://www.scopus.com/inward/record.url?scp=0034035151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034035151&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.0.CO;2-L

DO - 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.0.CO;2-L

M3 - Article

C2 - 10737981

AN - SCOPUS:0034035151

VL - 15

SP - 354

EP - 366

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 4

ER -